Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-02-11 @ 9:08 PM
Study NCT ID:
NCT00267020
Status:
COMPLETED
Last Update Posted:
2020-08-31
First Post:
2005-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer
Sponsor:
Organization: